01 2Zenara Pharma
02 6Ascent Innovative Medicines
03 2Aurobindo Pharma Limited
04 2Hetero Drugs
05 8MSD Pharmaceuticals
06 6Merck & Co
01 4Film-Coated Tablets
02 2Filmtabl
03 14TABLET;ORAL
04 2Tablet
05 4Blank
01 2DISCN
02 10RX
03 14Blank
01 6ERTUGLIFLOZIN
02 4SEGLUROMET
03 2STEGLATRO
04 2STEGLUJAN
05 2Segluromet
06 2Steglatro
07 2Steglujan
08 6Blank
01 6India
02 6Switzerland
03 14USA
Regulatory Info :
Registration Country : USA
Brand Name : ERTUGLIFLOZIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 216842
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : ERTUGLIFLOZIN
Dosage Form : TABLET;ORAL
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number : 216842
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Ertugliflozin; Sitagliptin Phosphate
Brand Name :
Dosage Form :
Dosage Strength : 2.5MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Ertugliflozin; Sitagliptin Phosphate
Brand Name :
Dosage Form :
Dosage Strength : 2.5MG; 1G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Ertugliflozin; Sitagliptin Phosphate
Brand Name :
Dosage Form :
Dosage Strength : 7.5MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Ertugliflozin; Sitagliptin Phosphate
Brand Name :
Dosage Form :
Dosage Strength : 7.5MG; 1G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ERTUGLIFLOZIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2023-07-13
Application Number : 216947
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ERTUGLIFLOZIN
Dosage Form : TABLET;ORAL
Dosage Strength : 15MG
Packaging :
Approval Date : 2023-07-13
Application Number : 216947
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERTUGLIFLOZIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2024-09-17
Application Number : 217071
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERTUGLIFLOZIN
Dosage Form : TABLET;ORAL
Dosage Strength : 15MG
Packaging :
Approval Date : 2024-09-17
Application Number : 217071
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : STEGLATRO
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2017-12-19
Application Number : 209803
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : STEGLATRO
Dosage Form : TABLET;ORAL
Dosage Strength : 15MG
Packaging :
Approval Date : 2017-12-19
Application Number : 209803
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE
Brand Name : STEGLUJAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG;EQ 100MG BASE
Packaging :
Approval Date : 2017-12-19
Application Number : 209805
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE
Brand Name : STEGLUJAN
Dosage Form : TABLET;ORAL
Dosage Strength : 15MG;EQ 100MG BASE
Packaging :
Approval Date : 2017-12-19
Application Number : 209805
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
Brand Name : SEGLUROMET
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2017-12-19
Application Number : 209806
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
Brand Name : SEGLUROMET
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2017-12-19
Application Number : 209806
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
Brand Name : SEGLUROMET
Dosage Form : TABLET;ORAL
Dosage Strength : 7.5MG;500MG
Packaging :
Approval Date : 2017-12-19
Application Number : 209806
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
Brand Name : SEGLUROMET
Dosage Form : TABLET;ORAL
Dosage Strength : 7.5MG;1GM
Packaging :
Approval Date : 2017-12-19
Application Number : 209806
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?